KRAS-driven ROS promote malignant transformation

Yongjoon Suh1, Su-Jae Lee1

  • 1Department of Life Science; Research Institute for Natural Sciences; Hanyang University ; Seoul, Korea.

Insights

Kirsten rat sarcoma viral oncogene homolog (KRAS) drives malignant transformation by increasing reactive oxygen species (ROS). This study identified the specific KRAS signaling pathway responsible for this ROS elevation and subsequent cellular changes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • The precise mechanisms of Kirsten rat sarcoma viral oncogene homolog (KRAS)-driven cellular transformation are not fully understood due to the intricate network of its downstream effectors.
  • KRAS is a key oncogene frequently mutated in various human cancers, highlighting its critical role in tumorigenesis.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which KRAS promotes cellular transformation.
  • To identify the specific signaling pathway responsible for KRAS-mediated reactive oxygen species (ROS) production and its role in malignant transformation.

Main Methods:

  • The study investigated the signaling cascade downstream of KRAS.
  • Researchers analyzed the role of reactive oxygen species (ROS) in KRAS-driven cellular transformation.
  • Specific molecular interactions within the identified pathway were examined.

Main Results:

  • KRAS activation leads to increased levels of reactive oxygen species (ROS) within cells.
  • The identified signaling cascade is KRAS/p38/PDPK1/PKCδ/p47(phox)/NOX1.
  • Elevated ROS mediated by this pathway are crucial for KRAS-driven malignant transformation.

Conclusions:

  • Reactive oxygen species (ROS) play a critical role in KRAS-driven malignant transformation.
  • The identified KRAS/p38/PDPK1/PKCδ/p47(phox)/NOX1 signaling cascade provides a new molecular framework for understanding KRAS oncogenesis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.8K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K